Analyst Ratings for Merck (MRK)
MRK Rating Summary
MRK Price Target Summary
- Highest: $107.00 (Cantor Fitzgerald)
- Lowest: $85.00 (Citi)
- Average: $96.47
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.47 (+6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 58%
Avg. $ Target:
$96.47 (+6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/6/2022 | Daiwa Securities | Narumi Nakagiri | Upgrade | Outperform (3) (Hold (3)) |
102.00 (89.00) |
92.64 (91.02) |
-1.75% | Details |
| 6/6/2022 | SVB Leerink | Joseph P. Schwartz | New Coverage | Outperform (N/A) |
102.00 (N/A) |
89.91 (91.02) |
1.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
MRK Ratings News
- Merck (MRK) Tops Analyst Estimates on Strong Keytruda, Gardasil, and Bridion Sales
- Morgan Stanley on Seagen (SGEN): 'We believe the reported ORR is at the high-end of investor expectations and should drive SGEN ~3-5%+ higher'
- Cowen Expects Positive Cohort K of EV-103 Data for Seagen (SGEN), Remains Skeptical About Buyout
- See More
